Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

Continuing education in opioid prescribing.

Grabois M, Webster LR.

JAMA. 2012 Nov 28;308(20):2082; author reply 2082-3. doi: 10.1001/jama.2012.13750. No abstract available.

PMID:
23188019
2.

Continuing education in opioid prescribing.

Kopelow M.

JAMA. 2012 Nov 28;308(20):2081-2; author reply 2082-3. doi: 10.1001/jama.2012.13747. No abstract available.

PMID:
23188018
3.

Curbing the opioid epidemic in the United States: the risk evaluation and mitigation strategy (REMS).

Nelson LS, Perrone J.

JAMA. 2012 Aug 1;308(5):457-8. doi: 10.1001/jama.2012.8165. No abstract available.

PMID:
22851109
4.

Pain & opioid addiction: hydrocodone update & zohydro. The paradigm for the epidemic..... continues.

Hall PB.

W V Med J. 2014 Nov-Dec;110(6):6-10. No abstract available.

PMID:
25651658
5.

Marshaling FDA Benefit-Risk Expertise to Address the Current Opioid Abuse Epidemic.

Gottlieb S, Woodcock J.

JAMA. 2017 Aug 1;318(5):421-422. doi: 10.1001/jama.2017.9205. No abstract available.

PMID:
28687816
6.

REMS; red tape, or a remedy for opioid abuse?

Porada S.

J Fam Pract. 2011 Sep;60(9 Suppl):S55-62. No abstract available.

PMID:
22442761
7.

The Toxicologist as Educator: Addressing Pain Management in the Midst of an Opioid Epidemic.

Beauchamp GA.

J Med Toxicol. 2015 Sep;11(3):279-80. doi: 10.1007/s13181-015-0491-y. No abstract available.

8.

Pain treatment, drug diversion, and the casualties of war.

Burgess F.

Pain Med. 2006 Nov-Dec;7(6):474-5. No abstract available.

PMID:
17112360
9.

The prescription drug misuse and abuse epidemic.

Thompson ME, Tommasello A, Long B.

J Am Pharm Assoc (2003). 2012 Sep-Oct;52(5):564-8. No abstract available.

PMID:
23023837
10.

Hailey.

Weeks WB.

JAMA. 2016 Nov 15;316(19):1975-1976. doi: 10.1001/jama.2016.10251. No abstract available.

PMID:
27838720
11.

We can make opioids safer.

Lipman AG.

J Pain Palliat Care Pharmacother. 2013 Jun;27(2):112-3. doi: 10.3109/15360288.2013.788609. Epub 2013 May 20. No abstract available.

PMID:
23688516
12.

Should CPD for opioid prescribing be mandatory?

Lemire F.

Can Fam Physician. 2015 Nov;61(11):1016, 1015. English, French. No abstract available.

13.

Could Delaware's medical marijuana law reduce harms from opioid analgesics?

Bachhuber MA, Saloner B, Cunningham CO, Feingold J, Barry CL.

Del Med J. 2014 Nov;86(11):341-3. No abstract available.

PMID:
25647864
14.

What is being done to address the new drug epidemic?

Dekker AH.

J Am Osteopath Assoc. 2007 Sep;107(9 Suppl 5):ES21-6. Review.

PMID:
17908827
15.

Wanted: a public health approach to prescription opioid abuse and diversion.

Joranson DE, Gilson AM.

Pharmacoepidemiol Drug Saf. 2006 Sep;15(9):632-4. No abstract available.

PMID:
16862603
16.

Medication-assisted therapies--tackling the opioid-overdose epidemic.

Volkow ND, Frieden TR, Hyde PS, Cha SS.

N Engl J Med. 2014 May 29;370(22):2063-6. doi: 10.1056/NEJMp1402780. Epub 2014 Apr 23. No abstract available.

17.

The Law and Social Values: Prescription Pain Killers.

Teo WZ, Bal BS.

Clin Orthop Relat Res. 2016 Sep;474(9):1924-9. doi: 10.1007/s11999-016-4940-y. Epub 2016 Jun 22. No abstract available.

18.

FDA committee: More restrictions needed on hydrocodone combination products.

Kuehn BM.

JAMA. 2013 Mar 6;309(9):862. doi: 10.1001/jama.2013.1609. No abstract available.

PMID:
23462764
19.

Opioid risk management: understanding FDA mandated risk evaluation and mitigation strategies (REMS).

Sloan PA.

J Opioid Manag. 2009 May-Jun;5(3):131-3. No abstract available.

PMID:
19662921
20.

Forecasting the opioid epidemic.

Burke DS.

Science. 2016 Nov 4;354(6312):529. No abstract available.

PMID:
27811241

Supplemental Content

Support Center